Prismic Pharmaceuticals
Board of Directors
Peter Moriarty, Founder, Chief Executive Officer and Chairman of the Board of Directors, has extensive pharmaceutical industry and entrepreneurial experience. He was a founder of Shire Pharmaceuticals, and worked for Warner-Lambert and Schering-Plough earlier in his career, including management in a number of overseas locations as well as the United States. Additionally, he has founded a number of other companies focused on increasing pharmaceutical sales force productivity and enhancing pharmaceutical companies’ relationships with their physician customers by the appropriate and cost-effective use of remote communication technology.
Zachary Dutton, Founder, President and member of the Board of Directors, has more than 15 years experience in the pharmaceutical industry and in the commercial development of medical foods. His career has included working with Primus Pharmaceuticals, an innovator in the field of medical foods, where his responsibilities included Business Development, Strategic Planning, and Marketing. Earlier in his career, in addition to managing his own consulting firm, he also managed a nutritional company focused on marketing natural products for maintaining mental health. He holds an MBA from the F.W. Olin School of Business at Babson College and a BA in Economics from Queen’s University in Kingston, Ontario, Canada.
Danilo Casadei Massari, Founder, President Europe and Head of Corporate Development, and member of the Board of Directors, has extensive experience as a senior pharmaceutical executive and as an entrepreneur. He was President and CEO of Fidia Pharmaceuticals, USA, and Director of International Corporate Development with Fidia Farmaceutici SpA. As an entrepreneur he has founded several pharmaceutical companies, including most recently, CM&D Pharma Limited, a company focused on prescription Medical Foods, which was acquired by Nestle Health Science in 2011. He is considered an expert in start-ups and co-ventures in the pharmaceutical sector.
Teo Forcht Dagi, MD, EVP, Chief Medical Officer, and member of the Board of Directors, has extensive experience both as a practicing neurosurgeon and as a venture capitalist prior to joining the founding team at Prismic. His experience also spans the areas of regulatory affairs and clinical trials. Dr. Dagi received an M.D. and M.P.H. from Johns Hopkins. He was trained in Neurosurgery and Neurophysiology at the Massachusetts General Hospital and was a Neuroresearch Foundation Fellow at Harvard Medical School. He also served as a Senior Registrar at the Neurosurgical Unit of the Guy's, Maudsley and King's College Hospitals in London, England. Also, he received an M.T.S. from Harvard, where he was appointed Joseph P. Kennedy Jr. Fellow and an M.B.A. in Finance and Strategic Planning from the Wharton School of the University of Pennsylvania, and also holds an A.B. from Columbia College.
Guru Ramanathan, Ph.D., Non-Executive member of the Board of Directors, is Chief Innovation Officer and Senior Vice President for General Nutrition Corp. (GNC). Prior to GNC, Dr. Ramanathan was a senior director for Royal Numico's U.S. subsidiaries, and earlier in his career was Medical Director for the U.S. subsidiary of Scotia Pharmaceuticals. Dr. Ramanathan is a Dental surgeon by profession, and has managed and conducted over 100 clinical studies. He holds an M.B.A. from Duke University′s Fuqua School of Business and a Ph.D. from Tufts University in healthcare innovation management.
Jith Veeravalli, Non-Executive member of the Board of Directors, is the Chairman of the Gencor group of companies (Gencor Nutrients, Gencor Pacific, Gencor Middle East, and Gencor Pacific Organics). Prior to founding Gencor in 1999, Mr. Veeravalli was the CEO of General Packaging Industries, and earlier in his career a Project Economist with the World Health Organization in Botswana. He holds an M.B.A. from the University of Toronto; a Master of Technology from IIT, Madras; and a Bachelor of Engineering from the University of Madras.
Zachary Dutton, Founder, President and member of the Board of Directors, has more than 15 years experience in the pharmaceutical industry and in the commercial development of medical foods. His career has included working with Primus Pharmaceuticals, an innovator in the field of medical foods, where his responsibilities included Business Development, Strategic Planning, and Marketing. Earlier in his career, in addition to managing his own consulting firm, he also managed a nutritional company focused on marketing natural products for maintaining mental health. He holds an MBA from the F.W. Olin School of Business at Babson College and a BA in Economics from Queen’s University in Kingston, Ontario, Canada.
Danilo Casadei Massari, Founder, President Europe and Head of Corporate Development, and member of the Board of Directors, has extensive experience as a senior pharmaceutical executive and as an entrepreneur. He was President and CEO of Fidia Pharmaceuticals, USA, and Director of International Corporate Development with Fidia Farmaceutici SpA. As an entrepreneur he has founded several pharmaceutical companies, including most recently, CM&D Pharma Limited, a company focused on prescription Medical Foods, which was acquired by Nestle Health Science in 2011. He is considered an expert in start-ups and co-ventures in the pharmaceutical sector.
Teo Forcht Dagi, MD, EVP, Chief Medical Officer, and member of the Board of Directors, has extensive experience both as a practicing neurosurgeon and as a venture capitalist prior to joining the founding team at Prismic. His experience also spans the areas of regulatory affairs and clinical trials. Dr. Dagi received an M.D. and M.P.H. from Johns Hopkins. He was trained in Neurosurgery and Neurophysiology at the Massachusetts General Hospital and was a Neuroresearch Foundation Fellow at Harvard Medical School. He also served as a Senior Registrar at the Neurosurgical Unit of the Guy's, Maudsley and King's College Hospitals in London, England. Also, he received an M.T.S. from Harvard, where he was appointed Joseph P. Kennedy Jr. Fellow and an M.B.A. in Finance and Strategic Planning from the Wharton School of the University of Pennsylvania, and also holds an A.B. from Columbia College.
Guru Ramanathan, Ph.D., Non-Executive member of the Board of Directors, is Chief Innovation Officer and Senior Vice President for General Nutrition Corp. (GNC). Prior to GNC, Dr. Ramanathan was a senior director for Royal Numico's U.S. subsidiaries, and earlier in his career was Medical Director for the U.S. subsidiary of Scotia Pharmaceuticals. Dr. Ramanathan is a Dental surgeon by profession, and has managed and conducted over 100 clinical studies. He holds an M.B.A. from Duke University′s Fuqua School of Business and a Ph.D. from Tufts University in healthcare innovation management.
Jith Veeravalli, Non-Executive member of the Board of Directors, is the Chairman of the Gencor group of companies (Gencor Nutrients, Gencor Pacific, Gencor Middle East, and Gencor Pacific Organics). Prior to founding Gencor in 1999, Mr. Veeravalli was the CEO of General Packaging Industries, and earlier in his career a Project Economist with the World Health Organization in Botswana. He holds an M.B.A. from the University of Toronto; a Master of Technology from IIT, Madras; and a Bachelor of Engineering from the University of Madras.
